ALMS vs. CVS

Last updated Apr 1, 2026

Compare and contrast key facts about Alumis Inc (ALMS) and CVS Health Corporation (CVS).

Performance

ALMS vs. CVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alumis Inc (ALMS) and CVS Health Corporation (CVS). The values are adjusted to include any dividend payments, if applicable.

ALMS vs. CVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024
ALMS Alumis Inc	125.72%	24.17%	-40.90%
CVS CVS Health Corporation	-8.76%	84.35%	-22.28%

Fundamentals

EPS ALMS : -$2.71 CVS : $1.39
PS Ratio ALMS : 90.00 CVS : 0.23
Total Revenue (TTM) ALMS : $22.12M CVS : $402.07B
Gross Profit (TTM) ALMS : $21.30M CVS : $55.36B
EBITDA (TTM) ALMS : -$424.43M CVS : $8.69B

Returns By Period

In the year-to-date period, ALMS achieves a 125.72% return, which is significantly higher than CVS's -8.76% return.

ALMS

• 1D: 9.01%
• 1M: -25.80%
• YTD: 125.72%
• 6M: 452.13%
• 1Y: 258.79%
• 3Y*: —
• 5Y*: —
• 10Y*: —

CVS

• 1D: 2.40%
• 1M: -10.11%
• YTD: -8.76%
• 6M: -3.17%
• 1Y: 10.05%
• 3Y*: 2.77%
• 5Y*: 2.63%
• 10Y*: -0.76%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ALMS vs. CVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALMS

ALMS Risk / Return Rank: 89
ALMS Sharpe Ratio Rank: 89
ALMS Sortino Ratio Rank: 93
ALMS Omega Ratio Rank: 92
ALMS Calmar Ratio Rank: 90
ALMS Martin Ratio Rank: 81

CVS

CVS Risk / Return Rank: 53
CVS Sharpe Ratio Rank: 55
CVS Sortino Ratio Rank: 46
CVS Omega Ratio Rank: 47
CVS Calmar Ratio Rank: 58
CVS Martin Ratio Rank: 59

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALMS vs. CVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alumis Inc (ALMS) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ALMS	CVS	Difference
Sharpe ratio Return per unit of total volatility	1.84	0.33	+1.52
Sortino ratio Return per unit of downside risk	3.28	0.60	+2.68
Omega ratio Gain probability vs. loss probability	1.43	1.09	+0.34
Calmar ratio Return relative to maximum drawdown	4.03	0.67	+3.35
Martin ratio Return relative to average drawdown	6.31	1.66	+4.66
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ALMS vs. CVS - Sharpe Ratio Comparison

The current ALMS Sharpe Ratio is 1.84, which is higher than the CVS Sharpe Ratio of 0.33. The chart below compares the historical Sharpe Ratios of ALMS and CVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ALMS	CVS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.84	0.33	+1.52
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.09	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.03	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.28	0.31	-0.03

Correlation

The correlation between ALMS and CVS is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ALMS vs. CVS - Dividend Comparison

ALMS has not paid dividends to shareholders, while CVS's dividend yield for the trailing twelve months is around 3.70%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ALMS Alumis Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
CVS CVS Health Corporation	3.70%	3.35%	5.93%	3.06%	2.36%	1.94%	2.93%	2.69%	3.05%	2.76%	2.15%	1.43%

Drawdowns

ALMS vs. CVS - Drawdown Comparison

The maximum ALMS drawdown since its inception was -78.95%, which is greater than CVS's maximum drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for ALMS and CVS.

Drawdown Indicators

	ALMS	CVS	Difference
Max Drawdown Largest peak-to-trough decline	-78.95%	-64.07%	-14.88%
Max Drawdown (1Y) Largest decline over 1 year	-72.19%	-16.44%	-55.75%
Max Drawdown (5Y) Largest decline over 5 years	—	-56.79%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-56.79%	—
Current Drawdown Current decline from peak	-26.52%	-25.47%	-1.05%
Average Drawdown Average peak-to-trough decline	-39.76%	-19.59%	-20.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	46.03%	6.66%	+39.37%

Volatility

ALMS vs. CVS - Volatility Comparison

Alumis Inc (ALMS) has a higher volatility of 29.29% compared to CVS Health Corporation (CVS) at 5.98%. This indicates that ALMS's price experiences larger fluctuations and is considered to be riskier than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ALMS	CVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.29%	5.98%	+23.31%
Volatility (6M) Calculated over the trailing 6-month period	89.40%	23.03%	+66.37%
Volatility (1Y) Calculated over the trailing 1-year period	141.57%	30.81%	+110.76%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	121.37%	29.36%	+92.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	121.37%	28.93%	+92.44%

Financials